Phillips-Medisize, a Molex company, is reporting that its Little Rock, AR, facility is fully compliant with Current Good Manufacturing Practice (CGMP) regulations. Described as 21 CFR part 820 compliant, the 380,000-sq-ft facility enhances Phillips-Medisize’s medical manufacturing services with such capabilities as molding, stamping, plating, and assembly, thus enabling vertical integration of manufacturing, electronics, and connected device solutions all in one site, the company reported in a news release.
The facility combines the innovative solutions and knowledge of Molex’s existing electronics production operations with Phillips-Medisize’s expertise in drug delivery and medical devices. For decades, Phillips-Medisize has been designing, developing, and manufacturing drug delivery devices. “We believe most drug delivery devices will benefit from being part of a connected health system. For that reason, we diligently pursue opportunities for lowering the cost of adding connectivity modules to drug delivery devices,” said Matt Jennings, CEO and president of Phillips-Medisize, in the release.
The facility also leverages existing dedicated white space along with Class 8 cleanroom space for medical manufacturing, the company reported.
[Image courtesy of PHILLIPS-MEDISIZE, A MOLEX COMPANY]
Editor's Note: If you have news you’d like to submit for potential inclusion in future weekly roundups, please send a press release and any related images to [email protected] with the subject line “Supplier Stories.”